Literature DB >> 18708058

Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.

Krishna P Bhat1, Christopher E Pelloski, Yujian Zhang, Se Hoon Kim, Clarissa deLaCruz, Michael Rehli, Kenneth D Aldape.   

Abstract

Here we show that in contrast to other cancer types, tumor necrosis factor (TNF)-alpha suppresses YKL-40 expression in glioma cell lines in a nuclear factor kappaB (NF-kappaB) dependent manner. Even though TNF-alpha causes recruitment of p65 and p50 subunits of NF-kappaB to the YKL-40 promoter in all cell types, recruitment of histone deacetylases (HDAC)-1 and -2, and a consequent deacetylation of histone H3 at the YKL-40 promoter occurs only in glioma cells. Importantly, using chromatin immunoprecipitation assays in frozen glioblastoma multiforme tissues, we show that YKL-40 levels decrease consistent with HDAC1 recruitment despite high levels of nuclear p-p65. This study presents a paradigm for NF-kappaB regulation of one of its targets in a strict cell type specific manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708058     DOI: 10.1016/j.febslet.2008.08.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40.

Authors:  Sandeep K Singh; Reetika Bhardwaj; Katarzyna M Wilczynska; Catherine I Dumur; Tomasz Kordula
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

2.  Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas.

Authors:  Fabio M Iwamoto; Andreas F Hottinger; Sasan Karimi; Elyn Riedel; Jocelynn Dantis; Maryam Jahdi; Katherine S Panageas; Andrew B Lassman; Lauren E Abrey; Martin Fleisher; Lisa M DeAngelis; Eric C Holland; Adília Hormigo
Journal:  Neuro Oncol       Date:  2011-08-10       Impact factor: 12.300

Review 3.  CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression.

Authors:  Raghunath Chatterjee; Charles Vinson
Journal:  Biochim Biophys Acta       Date:  2012-02-23

Review 4.  Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.

Authors:  Chun Geun Lee; Carla A Da Silva; Charles S Dela Cruz; Farida Ahangari; Bing Ma; Min-Jong Kang; Chuan-Hua He; Seyedtaghi Takyar; Jack A Elias
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

5.  RelB/p50 complexes regulate cytokine-induced YKL-40 expression.

Authors:  Reetika Bhardwaj; Jessie W Yester; Sandeep K Singh; Debolina D Biswas; Michael J Surace; Michael R Waters; Kurt F Hauser; Zhenqiang Yao; Brendan F Boyce; Tomasz Kordula
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

6.  NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.

Authors:  Yifu Song; Yang Jiang; Dongxia Tao; Zixun Wang; Run Wang; Minghao Wang; Sheng Han
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

7.  The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress.

Authors:  Jin-Ah Park; Jeffrey M Drazen; Daniel J Tschumperlin
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

8.  YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.

Authors:  Craig Horbinski; Guoji Wang; Clayton A Wiley
Journal:  Int J Clin Exp Pathol       Date:  2010-01-01

Review 9.  Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Authors:  Katrin Eurich; Mayuko Segawa; Satoko Toei-Shimizu; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

10.  Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.

Authors:  Desiree H Floyd; Benjamin Kefas; Oleksandr Seleverstov; Olga Mykhaylyk; Charli Dominguez; Laurey Comeau; Christian Plank; Benjamin Purow
Journal:  Neuro Oncol       Date:  2012-09-07       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.